Skip to main content
SpringerLink
Log in

Is There Still a Role for Radical Cystectomy?

  • Chapter
  • First Online:
Treating Urothelial Bladder Cancer

  • 475 Accesses

Abstract

Radical cystectomy (RC) with lymph node dissection (eLND) and neoadjuvant chemotherapy still represents the standard treatment for very high-risk non-muscle invasive (NMIBC) and muscle-invasive (MIBC) bladder cancer patients. Radical surgery provides recurrence-free (RFS) and overall survival (OS) rates of 68 and 66% after 5 years and of 60 and 43% after 10 years from RC, respectively. One of the major concerns about radical surgery regards the high morbidity/mortality rates related to the procedure and the consequent decreased patients’ quality of life. Therefore, bladder sparing techniques in a multimodal setting have been proposed and investigated, with promising results. However, to date, long-term oncological outcomes provided by bladder sparing techniques are still lacking. Moreover, patients who will not respond to bladder sparing treatments will, anyway, undergo salvage RC. For these reasons, radical surgery still represents the more convincing options since can provide good long-term outcomes and a decreased risk of local/regional recurrence thanks to the eLND. Moreover, RC is indicated also in locally advanced disease as well as in elderly patients. Finally, the possibility to perform an orthotopic neobladder could improve patients’ acceptability and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Witjes JA, Compérat E, Cowan NC, Gakis G, Hernández V, Lebret T, Lorch A, van der Heijden AG, Ribal MJ. EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;65(4):778–92.

    Article  Google Scholar 

  2. Ferlay J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374. https://www.ncbi.nlm.nih.gov/pubmed/23485231

    Article  CAS  PubMed  Google Scholar 

  3. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase No. 11. International Agency for Research on Cancer.

    Google Scholar 

  4. Freedman ND, et al. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Stein JP, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–75.

    Article  CAS  PubMed  Google Scholar 

  6. Hautmann RE, et al. Urinary diversion. Urology. 2007;69:17.

    Article  PubMed  Google Scholar 

  7. Babjuk M, Burger M, Compérat E, Gontero P, et al. EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and Cis). Eur Urol. 2017;71(3):447–61.

    Article  PubMed  Google Scholar 

  8. Mertens LS, et al. Prostate sparing cystectomy for bladder cancer: 20-year single center experience. J Urol. 2014;191:1250–5.

    Article  PubMed  Google Scholar 

  9. Stenzl A, et al. Cystectomy—technical considerations in male and female patients. EAU Updat Ser. 2005;3:138–46.

    Article  Google Scholar 

  10. Simone G, et al. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol. 2013;20:390–7.

    Article  PubMed  Google Scholar 

  11. Holmer M, et al. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol. 2009;27:521–6.

    Article  PubMed  Google Scholar 

  12. Poulsen AL, et al. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160:2015–9.

    Article  CAS  PubMed  Google Scholar 

  13. Jensen JB, et al. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol. 2012;19:39–47.

    Article  PubMed  Google Scholar 

  14. Dhar NB, et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008;179:873–8.

    Article  PubMed  Google Scholar 

  15. Zlotta AR. Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform? Eur Urol. 2012;61:243–4.

    Article  PubMed  Google Scholar 

  16. Zehnder P, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011;186:1261–8.

    Article  PubMed  Google Scholar 

  17. Koppie TM, et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer. 2006;107:2368–74.

    Article  PubMed  Google Scholar 

  18. Fleischmann A, et al. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23:2358–65.

    Article  PubMed  Google Scholar 

  19. Wright JL, et al. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008;112:2401–8.

    Article  PubMed  Google Scholar 

  20. Studer UE, et al. Morbidity from pelvic lymphadenectomy in men undergoing radical prostatectomy. Eur Urol. 2006;50:887.

    Article  PubMed  Google Scholar 

  21. Gschwend JE, et al. Prospective randomised study comparing limited versus extended lymphadenectomy in patients with bladder cancer. J Clin Oncol. 2016;34(15_suppl):4503.

    Google Scholar 

  22. Roth B, Wissmeyer MP, Zehnder P, Birkhäuser FD, Thalmann GN, Krause TM, Studer UE. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010;57(2):205–11.

    Article  PubMed  Google Scholar 

  23. Stein JP, et al. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol. 2006;24:296–304.

    Article  PubMed  Google Scholar 

  24. Dalbagni G, et al. Cystectomy for bladder cancer: a contemporary series. J Urol. 2001;165:1111–6.

    Article  CAS  PubMed  Google Scholar 

  25. Bassi P, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol. 1999;161:1494–7.

    Article  CAS  PubMed  Google Scholar 

  26. Ghoneim MA, et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol. 1997;158:393–9.

    Article  CAS  PubMed  Google Scholar 

  27. David KA, et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol. 2007;178:451–4.

    Article  PubMed  Google Scholar 

  28. Porter MP, et al. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol. 2011;29:252–8.

    Article  PubMed  Google Scholar 

  29. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and metaanalysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202–5.

    Article  Google Scholar 

  30. Hernández V, Espinos EL, Dunn J, MacLennan S, Lam T, Yuan Y, Compérat E, Cowan NC, Gakis G, Lebrét T, van der Heijden AG, Witjes JA, Ribal MJ. Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: a systematic review. Urol Oncol. 2017;35(9):539.e17–29. https://doi.org/10.1016/j.urolonc.2017.

    Article  Google Scholar 

  31. Ok JH, et al. Medical and surgical palliative care of patients with urological malignancies. J Urol. 2005;174:1177–82.

    Article  PubMed  Google Scholar 

  32. Ubrig B, et al. Extraperitoneal bilateral cutaneous ureterostomy with midline stoma for palliation of pelvic cancer. Urology. 2004;63:973–5.

    Article  PubMed  Google Scholar 

  33. Zebic N, et al. Radical cystectomy in patients aged > or = 75 years: an updated review of patients treated with curative and palliative intent. BJU Int. 2005;95:1211–4.

    Article  PubMed  Google Scholar 

  34. Miller DC, et al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 2003;169:105.

    Article  PubMed  Google Scholar 

  35. Figueroa AJ, et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer. 1998;83:141–7.

    Article  CAS  PubMed  Google Scholar 

  36. Geriatric assessment: methods for clinical decision making. NIH Consensus Statement Online N.I.o. Health, Editor. 1987, U.S. Department of Health & Human Services.

    Google Scholar 

  37. Froehner M, Brausi M, Herr HW, Muto G, Studer UE. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009;56(3):443–54.

    Article  PubMed  Google Scholar 

  38. Fonteyne V, Ost P, Bellmunt J, Droz JP, Mongiat-Artus P, Inman B, Paillaud E, Saad F, Ploussard G. Curative treatment for muscle invasive bladder cancer in elderly patients: a systematic review. Eur Urol. 2017;73(1):40–50.

    Article  PubMed  Google Scholar 

  39. Game X, et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol. 2001;39:525–9.

    Article  CAS  PubMed  Google Scholar 

  40. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer. 2005;104(1):36–43.

    Article  PubMed  Google Scholar 

  41. May M, et al. Results from three municipal hospitals regarding radical cystectomy on elderly patients. Int Braz J Urol. 2007;33:764–73.

    Article  PubMed  Google Scholar 

  42. Lughezzani G, et al. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer. 2011;117:103–9.

    Article  PubMed  Google Scholar 

  43. Brausi M, Selli C, Rossi A, Gavioli M, De Luca G, Peracchia G, Verrini G, Viola M, Romano A, Simonini G. Radical cystectomy (RC) in octogenarians Long-term experience of two high volume institutions. Eur Urol Suppl. 2015;14(/2):e534.

    Article  Google Scholar 

  44. Shariat SF, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006;176:2414–22.

    Article  PubMed  Google Scholar 

  45. Madersbacher S, et al. Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21:690–6.

    Article  PubMed  Google Scholar 

  46. Bruins HM, et al. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol. 2009;182:2182–7.

    Article  PubMed  Google Scholar 

  47. Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61:1039–47.

    Article  PubMed  Google Scholar 

  48. Hautmann RE, et al. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184:990–4.

    Article  PubMed  Google Scholar 

  49. Nielsen ME, et al. Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base. BJU Int. 2014;114:46–55.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Porter MP, et al. Hospital volume and 90-day mortality risk after radical cystectomy: a populationbased cohort study. World J Urol. 2011;29:73–7.

    Article  PubMed  Google Scholar 

  51. Jentzmik F, et al. The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol. 2012;30:733–9.

    Article  PubMed  Google Scholar 

  52. Hautmann RE, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion. Eur Urol. 2013;63:67.

    Article  PubMed  Google Scholar 

  53. Corcoran AT, et al. Variation in performance of candidate surgical quality measures for muscleinvasive bladder cancer by hospital type. BJU Int. 2015;115:230.

    Article  PubMed  Google Scholar 

  54. Ravi P, et al. Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis. BJU Int. 2014;113:733.

    Article  PubMed  Google Scholar 

  55. Irwin BH, Gill IS, Haber GP, Campbell SC. Laparoscopic radical cystectomy: current status, outcomes, and patient selection. Curr Treat Options Oncol. 2009;10(3–4):243–55.

    Article  PubMed  Google Scholar 

  56. Wilson TG, et al. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. Eur Urol. 2015;67:363.

    Article  PubMed  Google Scholar 

  57. Bochner BH, Dalbagni G, Sjoberg DD, et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol. 2015;67(6):1042–50.

    Article  PubMed  Google Scholar 

  58. Cohen SA, Mirheydar HS, Parsons JK, et al. Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort. Urology. 2014;84(2):314–9.

    Article  PubMed  Google Scholar 

  59. Novara G, Catto JW, Wilson T, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robotassisted radical cystectomy. Eur Urol. 2015;67(3):376–401.

    Article  PubMed  Google Scholar 

  60. Gandaglia G, Karl A, Novara G, De Groote R, Buchner A, D’Hondt F, Montorsi F, Stief C, Mottrie A, Gratzke C. Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: a comparison of two high-volume referral centers. Eur J Surg Oncol. 2016;42(11):1736–43.

    Article  CAS  PubMed  Google Scholar 

  61. Hussein AA, Saar M, May PR, Wijburg CJ, et al. Early oncologic failure after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol. 2017;197(6):1427–36.

    Article  PubMed  Google Scholar 

  62. Karam JA, Sagalowsky AI. Minimally invasive radical cystectomy for bladder cancer? Lancet Oncol. 2008;9:317.

    Article  PubMed  Google Scholar 

  63. Jacobi CA, Wenger FA, Ordemann J, et al. Experimental study of the effect of intraabdominal pressure during laparoscopy on tumour growth and port site metastasis. Br J Surg. 1998;85:1419.

    Article  CAS  PubMed  Google Scholar 

  64. Stolla V, Rossi D, Bladou F, et al. Subcutaneous metastases after coelioscopic lymphadenectomy for vesical urothelial carcinoma. Eur Urol. 1994;26:342.

    Article  CAS  PubMed  Google Scholar 

  65. Tsivian A, Sidi AA. Port site metastases in urological laparoscopic surgery. J Urol. 2003;169:1213.

    Article  PubMed  Google Scholar 

  66. Ost MC, Patel KP, Rastinehad AR, et al. Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor-alpha secretion: source of transitional-cell carcinoma portsite metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks. J Endourol. 2008;22:105–12.

    Article  PubMed  Google Scholar 

  67. Hewett PJ, Thomas WM, King G, et al. Intraperitoneal cell movement during abdominal carbon dioxide insufflation and laparoscopy. An in vivo model. Dis Colon Rectum. 1996;39:S62.

    Article  CAS  PubMed  Google Scholar 

  68. El-Tabey NA, Shoma AM. Port site metastases after robot-assisted laparoscopic radical cystectomy. Urology. 2005;66:1110.

    PubMed  Google Scholar 

  69. Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013;63:45–57.

    Article  PubMed  Google Scholar 

  70. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  71. Monteiro LL, Kassouf W. Radical cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: yes. Int Braz J Urol. 2017;43(2):184–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, B. Ramazzini Hospital, Carpi-Modena, Italy

    M. Brausi

Authors
  1. M. Brausi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Brausi .

Editor information

Editors and Affiliations

  1. University of Turin, Torino, Italy

    Francesco Soria

  2. University of Turin, Torino, Italy

    Paolo Gontero

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brausi, M. (2018). Is There Still a Role for Radical Cystectomy?. In: Soria, F., Gontero, P. (eds) Treating Urothelial Bladder Cancer . Springer, Cham. https://doi.org/10.1007/978-3-319-78559-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78559-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78558-5

  • Online ISBN: 978-3-319-78559-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation